L'Oréal has led a €35m funding round for French biotech ingredients company Abolis.
The investment will be used to expand the Essone-based company’s development of microbe-based beauty solutions.
Biotech is a key driver in the transformation of L'Oréal’s ingredient portfolio, Anne Colonna, Global Head of Advanced Research at L’Oréal, told Cosmetics Business.